SLCO1B1 and cancer: These results suggest that reduced OATP1B1 transport activity in cancer cachexia patients may be due to elevated inflammatory cytokines or other factors associated with cachexia progression rather than OATP1B1 polymorphism or CMPF (Sumimoto et al., 2025).